Literature DB >> 20237209

How should we define value in cancer care?

Scott Ramsey1, Adam Schickedanz.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20237209     DOI： 10.1634/theoncologist.2010-S1-1

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  12 in total

Review 1.  Overuse of Health Care Services in the Management of Cancer: A Systematic Review.

Authors:  Shrujal S Baxi; Minal Kale; Salomeh Keyhani; Benjamin R Roman; Annie Yang; Antonio P Derosa; Deborah Korenstein
Journal:  Med Care       Date:  2017-07       Impact factor: 2.983

Review 2.  Long-Term Survivorship after Hematopoietic Cell Transplantation: Roadmap for Research and Care.

Authors:  Minoo Battiwalla; André Tichelli; Navneet S Majhail
Journal:  Biol Blood Marrow Transplant       Date:  2016-11-03       Impact factor: 5.742

Review 3.  Quality measures for palliative care in patients with cancer: a systematic review.

Authors:  Arif H Kamal; Margaret Gradison; Jennifer M Maguire; Donald Taylor; Amy P Abernethy
Journal:  J Oncol Pract       Date:  2014-06-10       Impact factor: 3.840

4.  Understanding patients' values and preferences regarding early stage lung cancer treatment decision making.

Authors:  Donald R Sullivan; Karen B Eden; Nathan F Dieckmann; Sara E Golden; Kelly C Vranas; Shannon M Nugent; Christopher G Slatore
Journal:  Lung Cancer       Date:  2019-03-09       Impact factor: 5.705

5.  Resident Physicians and Cancer Health Disparities: a Survey of Attitudes, Knowledge, and Practice.

Authors:  Maria C Mejia de Grubb; Barbara Kilbourne; Roger Zoorob; Sandra Gonzalez; William Mkanta; Robert Levine
Journal:  J Cancer Educ       Date:  2016-09       Impact factor: 2.037

Review 6.  Stated and Revealed Preferences for Funding New High-Cost Cancer Drugs: A Critical Review of the Evidence from Patients, the Public and Payers.

Authors:  Tatjana E MacLeod; Anthony H Harris; Ajay Mahal
Journal:  Patient       Date:  2016-06       Impact factor: 3.883

Review 7.  National Institutes of Health Blood and Marrow Transplant Late Effects Initiative: The Healthcare Delivery Working Group Report.

Authors:  Shahrukh K Hashmi; Christopher Bredeson; Rafael F Duarte; Stephanie Farnia; Susan Ferrey; Courtney Fitzhugh; Mary E D Flowers; James Gajewski; Dennis Gastineau; Melissa Greenwald; Madan Jagasia; Patricia Martin; J Douglas Rizzo; Kimberly Schmit-Pokorny; Navneet S Majhail
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-03       Impact factor: 5.742

8.  Hypofractionation in prostate cancer radiotherapy: a step forward towards clinical routine.

Authors:  Barbara Vischioni; Rachele Petrucci; Francesca Valvo
Journal:  Transl Androl Urol       Date:  2019-12

9.  Therapy preferences in melanoma treatment--willingness to pay and preference of quality versus length of life of patients, physicians and healthy controls.

Authors:  Ramona Krammer; Lucie Heinzerling
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

10.  Value: The Next Frontier in Cancer Care.

Authors:  Bernardo H L Goulart
Journal:  Oncologist       Date:  2016-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.